Vergleich

AntibodyToTreponema Pallidum (Syphilis) ELISA Kit (EX.)

ArtNr DEIA070
Hersteller Creative Diagnostics
Menge 96 T
Kategorie
Typ Elisa-Kit
Specific against other
Citations 1.Fraser CM, et al. Complete genome sequence of Treponema pallidum, thesyphilis spirochete. Science 1998, 281:375. 2.Holmes KK, Lemon SM, Mardh P, Piot P, Sparling PF, Stamm WE, Wasserheit JM,Weisner PF. Chapters 33-36. In Sexually transmitted diseases, 3rd ed. NewYork: McGraw-Hill,1999. 3.Hook EW III, Martin DH, Stephens J, Smith BS, Smith K. A randomized,comparative pilot study of azithromycin versus benzathine penicillin G fortreatment of early syphilis. Sex Transm Dis 2002 Aug, 29(8):486-490. 4.Hook EW III, Stephens J, Ennis DM. Azithromycin compared with penicillin Gbenzathine for treatment of incubating syphilis. Ann Intern Med 1999 Sept 21,131(6):434-437. 5.Johns DR, Tierney M, Felsenstein D. Alteration in the natural history ofneurosyphilis by concurrent infection with the human immunodeficiency virus.N Engl J Med 1987, 316:1569-72.
ECLASS 10.1 32160605
ECLASS 11.0 32160605
UNSPSC 41116126
Lieferbar
Storage Conditions
Unopened Kit: Store at 2 - 8oC. Donot use past kit expiration date. Opened/Reconstituted Reagents: TMBSolution A, TMB Solution B, TMB Stop Solution, Wash Buffer, HRP-conjugateantibody Theabove mentioned reagents should be stored for up to 1 month at 2 - 8oC. Microplate Wells: Return unused wellsto the foil pouch containing the desiccant pack, reseal along entire edge ofzip-seal. May be stored for up to 1 month at 2 - 8oC.
Intended Use
This kit is anenzyme-linked immunosorbent assay (ELISA) for qualitative determination ofthe antibodies to Treponema pallidum (TP) in human serum or plasma. It isintended for screening of blood donors and as an aid for the diagnosis andmanagement of clinical conditions known as syphilis.
Sample
human serum or plasma
Full name
Treponema pallidum
Abbr
Syphilis anti-TP Kit (Ex.)
Principle Of The Test
With this kit, thedetection of anti-TP antibodies is achieved by antigen “sandwich” enzyme-linkedmethod (ELISA) where polystyrene microwell strips are pre-coated withrecombinant Treponema pallidum antigens expressed in E. coli. The sample isincubated in the microwells together with recombinant TP antigens conjugatedto horseradish peroxidase (HRP-Conjugate). The pre-coated antigens expressthe same epitopes as the HRP-Conjugate antigens, but are expressed indifferent hosts. In case of presence of anti-TP in the sample, duringincubation the pre-coated and conjugated antigens will be bound to the twovariable domains of the antibody and the specific antigens-antibodyimmunocomplex is captured on the solid phase. After washing to remove sampleand unbound conjugates, Chromogen solutions containing tetramethylbenzidine(TMB) and urea peroxide are added into the wells. In presence of theantigen-antibody-antigen “sandwich” complex, the colorless Chromogens arehydrolyzed by the bound HRP conjugate to a blue-colored product. The bluecolor turns yellow after stopping the reaction with sulfuric acid. The amountof color can be measured and is proportional to the amount of antibody in thesample. Wells containing samples negative for anti-TP remain colorless.
Reagents And Materials Provided
Microplate:96well polystyrene microplates (12 strips of 8 wells) coated with recombinantTP antigens, NegativeControl:1 ml, 1 vial, PositiveControl:1 ml, 1 vial, HRP-ConjugateAntigen:12ml, 1 vial, TMBSolution A: 6 ml, 1vial, TMBSolution B: 6 ml, 1vial, TMB StopSolution: 6 ml, 1vial, WashBuffer (20×): 50 ml, 1 vial, Microtiterplate sealers: 2 sheets, Plastic Sealable Bag: 1 unit.
Materials Required But Not Supplied
1.Validated microplate reader. 2.Eppendorf Tubes for dilution for samples and standards. 3.Deionized or distilled water. 4.Validated adjustable micropipettes, single and multi-channel. 5.Automatic microtiter plate washer or manual vacuum aspiration equipment. 6.37C incubator.
Precautions
1.The kit should be equilibrated to room temperature (20-23C) before opening anyvials and starting the assay. It is highly recommended that the solutions beused as soon as possible after rehydration. 2.When mixing or reconstituting protein solutions, always avoid foaming. 3.Do not mix or substitute reagents with those from other lots or sources. 4.To avoid cross-contamination, change pipette tips between additions of eachstandard level, between sample additions, and between reagent additions.Also, use separate reservoirs for each reagent. 5.Crystals could appear in the 20X wash solution due to high salt concentrationin the stock solutions. Crystals are readily dissolved at room temperature orat 37C before dilution of the buffer solutions. 6.Keep TMB Substrate protected from light. 7.The Stop Solution provided with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.
Specimen Treatment
Centrifugethe serum, plasma or cell culture supernatant samples for 10 minutes at1, 000×g. Remove particulates and assay immediately or aliquot and storesamples at -20C or -80oC. Avoid repeated freeze-thaw cycles.
ELISA Procedure
1.Allow the reagents and samples to reach room temperature for at least 15-30minutes. Check the Wash buffer concentrate for the presence of salt crystals.If crystals have formed in the solution, resolubilize by warming at 37oCuntil crystals dissolve. Dilute the stock Wash Buffer 1 to 20 with distilledor deionized water. Use only clean vessels to dilute the buffer. 2.Set the strips needed in strip-holder. and number sufficient number of wellsincluding three for the Negative control (e.g. B1, C1, D1), two for thePositive control (e.g. E1, F1 ) and one Blank (e.g. A1, neither samples norHRP-Conjugate antibody should be added into the Blank well). If the resultswill be determined by using dual wavelength plate reader, the requirement foruse of Blank well could be omitted. Use only number of strips requiredfor the test. 3.Add 100 ul of Positive control, Negative control, and specimen into theirrespective wells. Note: Use a separate disposal pipette tip for eachspecimen, Negative and Positive Control as to avoid cross-contamination.Cover the plate with the plate cover and incubate for 20 minutes at 37C.At the end of theincubation, remove and discard the plate cover. Wash each well 5 times withdiluted Wash buffer. Each time, allow the microwells to soak for 30-60seconds. After the final washing cycle, turn the plate down onto blottingpaper or clean towel, and tap it to remove any remainders. 4.Add 100ul HRP-Conjugate reagent to each well except the Blank, and mix bytapping the plate gently. Cover the plate with the plate cover and incubatefor 40 minutes at 37C.At theend of the incubation, remove and discard the plate cover. Wash each well 5times with diluted Wash buffer. Each time, allow the microwells to soak for30-60 seconds. After the final washing cycle, turn the plate down ontoblotting paper or clean towel, and tap it to remove any remainders. 5.Dispense 50 ul of TMB Solution A and 50 ul TMB Solution B solution into eachwell including the Blank, and mix by tapping the plate gently. Incubate theplate at 37C for 15minutes avoiding light. The enzymatic reaction between the TMB solutions andthe HRP-Conjugate antibody produces blue color in Positive control andanti-TP positive sample wells. 6.Using a multichannel pipette or manually, add 50 ul Stop Solution into eachwell and mix gently. Intensive yellow color develops in Positive control andanti-TP positive sample wells. 7.Calibrate the plate reader with the Blank well and read the absorbance at 450nm. If a dual filter instrument is used, set the reference wavelength at 630nm. Calculate the Cut-off value and evaluate the results. (Note: read theabsorbance within 5 minutes after stopping the reaction)
Interpretation Of Results And Quality Control
Eachmicroplate should be considered separately when calculating and interpretingresults of the assay, regardless of the number of plates concurrentlyprocessed. The results are calculated by relating each sample’s opticaldensity (OD) value to the Cut-off value (C.O.) of the plate. If the Cut-offreading is based on single filter plate reader, the results should becalculated by subtracting the Blank well OD value from the print reportvalues of samples and controls. In case the reading is based on dual filterplate reader, do not subtract the Blank well OD from the print report valuesof samples and controls. 1. Calculation of Cut-off value: Cut-offvalue (C.O.) = *Nc + 0.18 *Nc= the mean absorbance value for three negative controls. Ifone of the Negative control values does not meet the Quality control rangespecifications, it should be discarded and the mean value is calculated againusing the remaining two values. If more than one negative control OD valuedoes not meet the Quality control range specifications, the test is invalidand must be repeated. 2. Quality control range: Thetest results are valid if the Quality Control criteria are verified. It isrecommended that each laboratory must establish appropriate quality controlsystem with quality control material similar to or identical with the patientsample being analyzed 1)The OD value of the Positive control must be equal to or greater than 0.800at 450/630nm, or at 450nm after blanking. 2)The OD value of the Negative control must be less than 0.100 at 450/630nm orat 450nm after blanking. 3)The OD value of the Blank well, which contains only Chromogen and Stopsolution, is less than 0.080 at 450 nm. 3. Interpretations of the results: (S= the individual optical density (OD) of each specimen) Negative Results (S/C.O.<1): Samples givingabsorbance less than the Cut-off value are negative for this assay, whichindicates that no anti-TP antibodies have been detected with this kit.Therefore, the patient is probably not infected and there are no serologicalindications for past infection with TP. Positive Results (S/C.O.>=1): Samplesgiving an absorbance greater than or equal to the Cut-off value areconsidered initially reactive , which indicates that TP antibodies have beendetected using this anti-TP ELISA kit. Retesting in duplicates of any initiallyreactive sample is recommended. Repeatedly reactive samples can be consideredpositive for antibodies to Treponema pallidum and therefore there areserological indications for current or past infection with TP. Any blood unitcontaining antibodies to Treponema pallidum should be immediately discarded. Borderline (S / C.O. = 0.9-1.1): Sampleswith absorbance to Cut-off ratio between 0.9 and 1.1 are consideredborderline and retesting of these samples in duplicates is recommended toconfirm the results. Repeatedly positive samples could be considered positivefor antibodies to TP. Retestingof these samples in duplicates is recommended. Repeatedly positive samplescould be considered positive for Treponema pallidum. Follow-up andsupplementary testing any positive with other analytical system is required.
Detection Method
Competitive Enzyme Immunoassay
Quality Control
Eachmicroplate should be considered separately when calculating and interpretingresults of the assay, regardless of the number of plates concurrentlyprocessed. The results are calculated by relating each sample’s opticaldensity (OD) value to the Cut-off value (C.O.) of the plate. If the Cut-offreading is based on single filter plate reader, the results should becalculated by subtracting the Blank well OD value from the print reportvalues of samples and controls. In case the reading is based on dual filterplate reader, do not subtract the Blank well OD from the print report valuesof samples and controls. 1. Calculation of Cut-off value: Cut-offvalue (C.O.) = *Nc + 0.18 *Nc= the mean absorbance value for three negative controls. Ifone of the Negative control values does not meet the Quality control rangespecifications, it should be discarded and the mean value is calculated againusing the remaining two values. If more than one negative control OD valuedoes not meet the Quality control range specifications, the test is invalidand must be repeated. 2. Quality control range: Thetest results are valid if the Quality Control criteria are verified. It isrecommended that each laboratory must establish appropriate quality controlsystem with quality control material similar to or identical with the patientsample being analyzed 1)The OD value of the Positive control must be equal to or greater than 0.800at 450/630nm, or at 450nm after blanking. 2)The OD value of the Negative control must be less than 0.100 at 450/630nm orat 450nm after blanking. 3)The OD value of the Blank well, which contains only Chromogen and Stopsolution, is less than 0.080 at 450 nm. 3. Interpretations of the results: (S= the individual optical density (OD) of each specimen) Negative Results (S/C.O.<1): Samples givingabsorbance less than the Cut-off value are negative for this assay, whichindicates that no anti-TP antibodies have been detected with this kit.Therefore, the patient is probably not infected and there are no serologicalindications for past infection with TP. Positive Results (S/C.O.>=1): Samplesgiving an absorbance greater than or equal to the Cut-off value areconsidered initially reactive , which indicates that TP antibodies have beendetected using this anti-TP ELISA kit. Retesting in duplicates of any initiallyreactive sample is recommended. Repeatedly reactive samples can be consideredpositive for antibodies to Treponema pallidum and therefore there areserological indications for current or past infection with TP. Any blood unitcontaining antibodies to Treponema pallidum should be immediately discarded. Borderline (S / C.O. = 0.9-1.1): Sampleswith absorbance to Cut-off ratio between 0.9 and 1.1 are consideredborderline and retesting of these samples in duplicates is recommended toconfirm the results. Repeatedly positive samples could be considered positivefor antibodies to TP. Retestingof these samples in duplicates is recommended. Repeatedly positive samplescould be considered positive for Treponema pallidum. Follow-up andsupplementary testing any positive with other analytical system is required.
Limitations
1.Non-repeatable positive result may occur due to the general biological andbiochemical characteristics of ELISA method. The test is designed to achievevery high performance characteristics of high sensitivity and specificity. 2.Any positive results must be interpreted in conjunction with patient clinicalinformation and other laboratory testing results. 3.If, after retesting of the initially reactive samples, the assay results arenegative, these samples should be considered as non-repeatable (falsepositive) and interpreted as negative. As with many very sensitive ELISAassays, false positive results can occur due to the several reasons, most ofwhich are related but not limited to inadequate washing step. 4.Common sources for mistakes: kits beyond the expiry date, bad washingprocedures, contaminated reagents, incorrect assay procedure steps, insufficient aspiration during washing, failure to add samples or reagents, equipment, timing, volumes, sample nature and quality. 5.The prevalence of the marker will affect the assay’s predictive values. 6.This kit is intended ONLY for testing of individual serum or plasma samples.Do not use it for testing of cadaver samples, saliva, urine or other bodyfluids, or pooled (mixed) blood. 7.This is a qualitative assay and the results cannot be use to measureantibodies concentrations.
Indications Of Instability Or Deterioration Of The Reagents
1.Values of the Positive or Negative controls, which are out of the indicatedQuality control range, are indicator of possible deterioration of thereagents and/or operator or equipment errors. In such case, the resultsshould be considered as invalid and the samples must be retested. In case ofconstant erroneous results classified as due to deterioration or instabilityof the reagents, immediately substitute the reagents with new ones, orcontact our technical support for further assistance. 2.If after mixing of the TMB Solution A and B into the wells, the color of themixture turns blue within few minutes, do not continue carrying out thetesting and replace the reagents with fresh ones.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 96 T
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 18.12.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen